TGM2 and myeloid sarcoma: Recently, our group and others identified TG2 dysregulation in cadaveric MS brain samples and in the CNS of rodents with EAE (experimental autoimmune encephalomyelitis) [38], highlighting its role in the pathogenesis of MS.